CONNECT WITH US
HealthTech

HealthTech

Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

TechCrunch — Biotech & Health logo

Published on

Add as a preferred source on Google
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

Science Corporation CEO Max Hodak announced that the company has implanted its vision-restoring chip, PRIMA, into its first patient with Stargardt disease, an inherited eye disease that gradually destroys central vision. Hodak, the former president and co-founder of Neuralink, the brain implant company, explained on stage at TechCrunch Disrupt how the company’s work with PRIMA fits into its broader pursuit of a novel brain-computer interface (BCI).

“The retina is part of the central nervous system,” Hodak said on stage. “We consider cochlear implants, retinal prostheses, motor prostheses, these are all different types of BCIs.”

Hodak outlined a vision in which BCIs expand into a wide range of medical technology applications, rather than simply being a way to control computers.

While PRIMA is commercially available in Europe for patients who’ve lost their sight to geographic atrophy, an advanced form of age-related macular degeneration, the company believes its approach can be applied to multiple diseases, including Stargardt disease, which is currently considered incurable.

Stargardt disease affects the outer retina, causing the gradual death of the eye’s light-sensing cells while potentially sparing the inner retina, the part that passes visual signals onto the brain. It causes a central blind spot that gradually enlarges over time. Approximately 150,000 people worldwide have lost vision due to the disease.

“One of the nice things about this device approach, when I was saying the brain’s a computer, vision is electrical potential, like electrical activity down the optic nerve,” Hodak said.



Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.